Appraisals - ASAR & FAR
- 27/01/2022
- Appraisal Report: buprenorphine (Sixmo) 4262
-
-
- 24/02/2020
- Appraisal Report: bromfenac (Yellox) 1025
-
-
- 24/02/2020
- Appraisal Report: bromfenac (Yellox) 1025
-
-
- 07/06/2022
- Appraisal Report: bevacizumab (Avastin) 5044
-
-
- 09/07/2020
- Appraisal Report: belimumab (Benlysta) 3778
-
-
- 26/02/2020
- Appraisal Report: belatacept (Nulojix) 430
-
-
- 26/06/2019
- Appraisal Report: ataluren (Translarna) 3911
-
-
- 09/08/2019
- Appraisal Report: argatroban (Exembol) 1405
-
-
- 31/07/2019
- Appraisal Report: aprepitant (EMEND) 2937
-
-
- 24/02/2020
- Appraisal Report: aflibercept (Zaltrap) 456
-
-
- 31/07/2019
- Appraisal Report: adalimumab (Humira) 3371
-
-